Abilify 30 mg Tablets: SPC Summary

What are Abilify 30 mg tablets?

Abilify is a prescription medicine whose active substance is aripiprazole. It is an atypical antipsychotic used in the treatment of certain mental health conditions.

The tablet is taken by mouth and is commonly used as part of a wider treatment plan. The exact dose and duration depend on the condition being treated and the individual patient’s response.

What is Abilify used for?

Based on the information in the original content, Abilify is indicated for:

• Schizophrenia in adults and adolescents aged 15 years and older.
• Moderate to severe manic episodes associated with Bipolar I Disorder.
• Adjunctive treatment for major depressive disorder in adults.

Use should always be guided by a healthcare professional, who can consider the person’s medical history, current medicines, and overall clinical situation.

How does aripiprazole work?

Aripiprazole acts on brain neurotransmitter systems, especially dopamine and serotonin. The original content describes it as a partial agonist at the D2 dopamine receptor, which means it can modulate receptor activity depending on the level of dopamine present.

This mechanism is thought to help reduce symptoms linked with psychosis and mood instability. The exact way it produces its clinical effects is still being studied.

What is the usual dosage information?

The original content states that dosage varies depending on the condition, age, and response to treatment. It also notes that the maximum daily dose is 30 mg.

Examples mentioned in the source content include:

• Adults: an initial dose typically between 10 mg and 15 mg per day.
• Adolescents aged 13 to 17 years with schizophrenia: an initial dose of 10 mg daily, with adjustment based on clinical response.
• Bipolar I Disorder in adults: treatment usually begins at 15 mg.

For any dose-related question, the official product information and a healthcare professional should be the first reference point.

What warnings and precautions are listed?

The original content highlights several important precautions:

• Increased mortality risk in elderly patients with dementia-related psychosis.
• Suicidal thoughts and behaviours may be a concern, particularly in young adults and adolescents.
• Metabolic changes such as weight gain, hyperglycaemia, and dyslipidaemia may require monitoring.

It also notes that patients may need assessment for a history of seizures, cardiovascular disease, or other psychiatric conditions before treatment is started.

What side effects are mentioned?

The source content lists the following common side effects:

• Akathisia (inner restlessness)
• Somnolence (drowsiness)
• Extrapyramidal symptoms (movement-related effects)
• Weight gain and metabolic changes

It also mentions a rare but serious reaction, neuroleptic malignant syndrome, which needs urgent medical attention if symptoms such as high fever, muscle rigidity, or altered mental status occur.

What should patients and carers check with a clinician or pharmacist?

If you are reviewing Abilify 30 mg tablets, it is sensible to confirm the following with the official leaflet or a healthcare professional:

• The exact indication for use.
• The dose and how it should be taken.
• Any monitoring needed during treatment.
• Possible interactions with other prescribed or over-the-counter medicines.
• What to do if side effects appear or symptoms change.

Frequently asked questions

Key takeaways

Abilify 30 mg tablets contain aripiprazole and are used for selected psychiatric conditions. The most important points are the indication, the prescribed dose, and the need for monitoring of side effects and safety concerns.

Because treatment decisions are individual, the official product information and professional advice should always be used alongside this summary.